Curaleaf Appoints Tyneeha Rivers As Chief People Officer
May 24, 2022
Global Sciences is a vertically integrated hemp-based CBD producer, extractor, and branding investment vehicle which currently owns multiple product categories through multiple subsidiaries, including, Aethics, Cannaoil, Strasburg Pharms Certified, Resinosa, and Pure BioPlastics. The company began as a specialist in a wide range of CBD products, setting new standards of both quality and productivity. Through their mission to provide pure and natural products to the modern consumer new opportunities and investments sparked wider involvement in the wellness field.
If Global Sciences sounds familiar but you’re not sure why, it’s because the company had actually established itself as CBD Global Sciences prior to 2022. Its growth and success called for a broader reach, however, and CBD was dropped from the name.
This pivot came as a result of discovering new opportunities that could create value for shareholders, no longer limiting product development to the CBD market alone.
“The name change will not impact the Company’s ability to increase revenues and profitability within the CBD and distribution industries, it will enhance its ability to better define itself as it explores other areas in the field of wellness sciences,” the company wrote.
Simply put, Global Sciences is now taking its piece of an even larger pie, pivoting from operation in a $3.5 billion industry in 2021 to one projected to reach $26.6 billion by 2025.
“In the ever-changing industry of CBD the team at Global Sciences has become accustomed to quickly pivoting to provide better value to its customers and shareholders,” said CEO Brad Wyatt. “This change is the beginning of more exciting news that will be presented in the near term. We are still very active in the CBD landscape and presenting wins for our company with lower cost manufacturing and more points of distribution which will translate into increased revenues and improved profitability. We are very excited about 2022 and beyond for our company and its shareholders.”
Global Science’s first move after officially filing for its name change was announcing the acquisition of 100% of BioPlastics Inc, a Colorado based manufacturer of reusable, recyclable, and biodegradable plastics.
As a developer of multiple consumer products, the acquisition could enable Global Sciences to apply a sustainable approach to the distribution and packaging of products for its subsidiaries. But it also grants Global Sciences access to technology that will create bioplastics from non-food biomass, which includes hemp. Pure BioPlastics was established to supply bio-based solutions to our dependence on oil-based plastics, swapping them out with more sustainable bio-based plastics instead. One of the company’s breakthroughs include the development of its continuous countercurrent reactor technology (CCR), which can now support a wide variety of “Designer Biodegradable Products,” such as straws, lids, and even plastic parts of cars and aircrafts.
Bioplastics had a global market value of approximately $7.6 billion in 2021 and is expected to nearly double by 2028 to $15.5 billion.
In January, Global Sciences launched the new product line “Dog Unleashed CBD” in partnership with Dog the Bounty Hunter. Duane “Dog” Chapman has starred in many reality tv shows about his bounty hunting experiences and personal life. Dog currently has a spin-off entitled Dog’s Most Wanted in production at WGN America and his next project, Dog’s Unleashed, is set to premiere in 2021 on the streaming site Unleashed.
His past shows have set viewership records on A&E, WGN and CMT, but Dog’s Unleashed is expected to surpass even those. Dog will be doing many interviews on prominent talk shows about both his series and Dog Unleashed CBD.
Dog struggled for years to find a way to ease the physical and mental pain that came with his job as a bounty hunter. He was always wary of over-the-counter or prescription painkillers, so he was thrilled when he found CBD.
Eventually he decided to create his own brand, but he wanted to work with a company that he knew he could count on to always deliver quality. He chose to partner with Global Sciences because they completely control the product with stringent chain of custody requirements. They organically grow hemp and use a cold fusion process to extract the cannabinoids, leading to a full spectrum and pure CBD product. Dog has stated that
Dog Unleashed CBD consists of a robust line of CBD products, aimed at addressing many bodily pains with a natural approach. The product launch will coincide with the release of Dog’s new show, streaming on the Unleashed internet platform.
The initial product line will offer 12 different SKUs in three different strengths 1000MG, 2000MG and 3500MG– all of which are infused with a lab tested, full spectrum CBD oil. The offerings will also include both lotions and salves. All products meet established state and federal requirements of no more than 0.3% delta-9-tetrahydrocannabinol and can be sold in all 50 states. Global Sciences will expand the product offerings over the next two quarters in 2021 including CBD infused confectionary products and a hydration line featuring multi flavored energy drinks.
Learn more about Dog and Dog Unleashed CBD here.
The Aethics brand was born from the need for a trusted source for CBD (cannabidiol) sports wellness products. Global Sciences founders saw a leadership void in this fast growing sports category, and a unique opportunity to create a brand that concentrates on individuals living active lifestyles.
Consumers are requesting natural, non-addicting solutions for pain relief, inflammation, insomnia, anxiety, nausea and related common and chronic ailments. The Aethics brand presents an informative, ethical destination for the athlete that is looking for safe alternatives in caring for their body and mind.
Aethics boasts 3 topical CBD creams, 5 CBD infused drinks and 3 CBD performance drops.
@TeamAethics | www.aethics.com
The CannaOil brand was created in 2016 to provide the highest quality CBD derived from hemp products on the market.
The hemp oil is obtained using a super cold extraction process on local Colorado plants, maximizing productions and quality. All hemp used to create the products is grown locally at Strasburg Pharms, which is pesticide free and only uses natural additives to craft the most effective product on the market.
Strasburg Pharms Certified is a stamp of CBD Hemp quality placed on the company’s products, and awarded to worthy third party companies throughout the US looking to develop their own brands and white labeled CBD products.
Certification ensures the following:
So what is hemp and CBD, and where’s the market for it? While there are many common misconceptions about the nature of hemp and CBD, you’d have to be living under a rock to think that there isn’t a huge market for these products.
Hemp is a part of cannabis, a type of flower in the Cannabaceae family, but it is not used to get you high like one hearing “cannabis” might think. THC (tetrahydrocannabinol) is a cannabinoid, or chemical, found in cannabis and is responsible for the “high” effects associated with the cannabis plant. To be legally labeled as hemp, there must be .3% or less THC in the product.
Most industrial hemp doesn’t produce many buds, and almost all the THC in the cannabis plant is formed in resin glands on the buds and flowers. Since industrial hemp isn’t grown to cultivate said buds, it lacks the main components that would get someone high. Industrial hemp also has higher concentrations of cannabidiol (CBD) which actually lessens the psychoactive effects of THC.
While the health benefits of the CBD continue to be explored, the World Health Organization has stated that CBD presents no evidence of abuse or dependence potential. The CBD retail industry is already booming, with a plethora of products marketed as treatments for chronic pain, anxiety, depression, and more. However, it seems the market is on the cusp of another swell.
Leading cannabis researchers BDS Analytics and Arcview Market Research projects that the collective market for CBD sales in the U.S. will exceed $20 billion by 2024. This is a slight increase from the recent estimation of $15 billion by 2025 by New York-based investment bank Cowen & Co.
BDS analytics also predicted a CBD growth rate of 49% across all distribution channels by 2024. There’s already a significant market for CBD products and it’s only going to get larger. As it continues to expand, so does the need for the most pure, full spectrum CBD possible, which CBD Global is in the perfect position to capitalize on.
Strasburg Pharms is a wholly owned subsidiary of Global Sciences and controls approximately 179 contiguous acres of farmable land through lease and purchase. The company also has the opportunity to purchase up to an additional 3,485 acres contiguous to its current 179 acres in Strasburg, Colorado.
The leaders behind Strasburg Pharms want to bring organically grown and genetically beneficial hemp to market in the most economical way possible. With more than 60 years of agricultural experience on their team, they aim to provide the highest quality hemp in their sector.
Industrial hemp can be genetically bred to produce high CBD potency and low THC potency. To be clear, CBD is a non-psychoactive cannabinoid, so it can be used without gaining the feelings of lethargy and/or dysphoria. CBD doesn’t make you “high,” but it does offer many healing and calming benefits that consumers rely on.
All the farms cannabidiol comes from organically grown, lab extracted and tested, industrial hemp.Their plants are hand picked to produce full spectrum CBD with maximum potency and less than or equal to .3% THC. They never use chemicals or pesticides in their completely all-natural approach, regulated by the Department of Agriculture.
Strasburg Pharms also uses a cold fusion extraction process, where the terpenes and cannabinoids are sealed with super cold temperatures. It’s one of the most natural and effective ways to extract the pure oils from the plant matter. All of this combined means that Strasburg Pharms can produce massive and growing quantities of high potency and quality CBD.
Chief Executive Officer and President
Mr. Wyatt is the cofounder/CEO of CBD Global as well as Strasburg Pharms, SMBT, and CannaOil, which are all wholly owned subsidiaries of CBD Global.
Professional Background includes executive positions with Federal Mogul, Sears Roebuck, and the Target Corporation.
Founder of MAC5 Mortgage Inc. which operates in 6 states and employs over 100 people.
Scott Darnell is the Marketing Manager for CBD Global.
He is responsible for linking the innovations of the company’s product team to the customer-focused operations of the business, thus building the company’s global brand, creating consumer awareness and advocacy, and driving customer preference.
Chief Operating Officer
Mr. Dooley co-founded MAC5 Mortgage Inc. with Brad Wyatt in 2006.
Mr. Dooley holds a bachelor’s degree in Biology and brings to the team a breadth of knowledge and experience in management and startups.
Mr. Wyatt is currently the Supply Chain and Logistics Consultant with CBD Global.
Prior to this role, Jake was an expert in the supply chain area with various firms including Gencoa, FEDEX, and Sears Roebuck.
Mr. Wyatt holds a M.S in Transportation Management from Florida Institute of Technology and a degree in business administration from University of Tennessee.
Chief Financial Officer
Alexander McAulay CPA, CA is an experienced public company CFO.
Alex founded the successful Naked Brand Group Inc. (NASDAQ:NAKD) and led the company as its COO and CFO.
Alex is currently the CFO of Marifil Mines Limited (TSX-V:MFM), GreenStar Biosciences Corp. (CSE:GSTAR) and is the owner of a licensed accounting practice, ACM Management Inc., providing CFO advisory services to public companies.